Alice Ebel is the Head of Regulatory Operations at Grünenthal GmbH in Germany since January 2016. In this position she manages a team which is responsible to provide full operational support in the planning and execution of global regulatory strategies for the company’s product portfolio. In addition, she is currently managing the replacement of an existing RIM system and is actively involved in preparing the company for the IDMP requirements. Alice holds degrees in Biology and Regulatory Affairs and has gained 11 years hands-on experience in international drug development from pre-clinical through clinical studies as well as marketing authorisation applications and life cycle management in the role of a project manager and as a regulatory project lead. She has also actively contributed to the company’s business development by performing regulatory due diligence assessments of potential licensing or acquisition targets. Her motto: “A goal without a plan is just a wish.” ― Antoine de Saint-Exupery